Sars-Cov2 Pneumonia in Mexico

Authors

  • Bertha Zenaida Acevedo Martínez Department of Surgery of the General Hospital "Dr. Rubén Leñero", Ministry of Health of Mexico City
  • Óscar Escalante Piña Department of Surgery, Regional Military Hospital of Tampico, Tamaulipas, Ministry of National Defense
  • Javier López Jarquin Emergency Service of the General Hospital of Zone No. 29, "Dr. Belisario Domínguez", Mexican Institute of Social Security
  • Olaf Alejandro López Arias Anaesthesia Service of the General Hospital "Dr. Rubén Leñero", Ministry of Health of Mexico City
  • Bruno París Rómero Ángeles Central Offices of the Mexican Institute of Social Security
  • Marta Estela Miranda Rendón "Dr. Atanasio Garza Ríos" Health Center, Ministry of Health of Mexico City
  • Karla Ixchel Contreras Solis Emergency Department of the Regional Hospital "Lic. Adolfo López Mateos" of the Institute of Security and Social Services of State Workers
  • Carolina Jimarez Franco Emergency Service of the High Specialty Medical Unit of the General Hospital "Dr. Gaudencio González Garza" National Medical Center "La Raza" of the Mexican Institute of Social Security
  • Morelos Adolfo García Sánchez Surgery Department of the General Hospital, Ministry of Health of Mexico City, "Dr. Rubén Leñero"

DOI:

https://doi.org/10.14738/bjhmr.115.17658

Keywords:

Pneumonia, Atypical, SARS-COV2, Covid 19, Hypoxia, C-reactive protein

Abstract

Introduction: pneumonia is a very common pathology and, in some countries, it is a fatal in-hospital complication. However, at the end of November 2019, the first cases of acute respiratory syndrome were reported in people in the city of Wuhan, China. It was initially called atypical pneumonia. Objective: to report the experience of SARS-COV2 pneumonia at the "El Vergel" Zone Military Hospital. Method: this is a retrospective, longitudinal, cross-sectional, observational and descriptive study, in a period of time carried out in a second-level medical care hospital. Results: 220 patients with SARS-COV2 pneumonia disease are reported. Of which 145 male patients are 66% and 75 female patients representing 34%. Confirmation of the diagnosis for covid 19 was carried out by nasopharyngeal PCR for Sars-cov-2. Most of the cases are severe and present hypoxia on admission, classifying the covid 19 disease as mild (3.6%), moderate (15.9%) and severe (80.4%). Conclusions: atypical pneumonia due to SARS-COV2 is a disease with a high level of virulence and/or pathogenicity in terms of clinical progression and aggressiveness, its mortality is overwhelming, hence the importance of presenting this research.

Downloads

Published

2024-10-08

How to Cite

Martínez, B. Z. A., Piña, Óscar E., Jarquin, J. L., Arias, O. A. L., Ángeles, B. P. R., Rendón, M. E. M., Solis, K. I. C., Franco, C. J., & Sánchez, M. A. G. (2024). Sars-Cov2 Pneumonia in Mexico. British Journal of Healthcare and Medical Research, 11(5), 98–108. https://doi.org/10.14738/bjhmr.115.17658

Most read articles by the same author(s)

<< < 1 2